GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats

Ajaykumar N. Sharma, Sagar S. Ligade, Jay N. Sharma, Praveen Shukla, Khalid M. Elased, James B. Lucot

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)519-527
Number of pages9
JournalMetabolic Brain Disease
Volume30
Issue number2
DOIs
StatePublished - Apr 1 2015

ASJC Scopus Subject Areas

  • Biochemistry
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Keywords

  • Antipsychotics
  • Depression
  • GLP-1 receptor agonist
  • Liraglutide
  • Olanzapine

Disciplines

  • Chemicals and Drugs
  • Medical Toxicology
  • Medicine and Health Sciences

Cite this